3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Lymphoid
3
Head & Neck
2
Sarcoma
1
Gastrointestinal
1
Conditions
Lymphoma
2
Head and Neck Neoplasms
2
Thyroid Nodule
1
Interventions
pembrolizumab
9
Nivolumab
5
epacadostat
2
Thiotepa
2
Nonlinear Optical Microscopy
2
Magnetic Resonance Spectroscopy
2
Magnetic Resonance Imaging
2
Ipilimumab
2
Filgrastim
2
Cytological Techniques
2
Cyclophosphamide
2
Biopsy, Fine-Needle
2
Biopsy
2
vocimagene amiretrorepvec
1
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
spartalizumab
1
sapanisertib
1
romidepsin
1
relatlimab
1
poly ICLC
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
motexafin gadolinium
1
larotrectinib
1
ipatasertib
1
fludarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Lymphoma
×
Cytological Techniques
×
Head & Neck
×
Clear all
NCT05010369
2025-06-26
DOLPHIN-VIVO
University of Exeter
Phase NA
Terminated
14 enrolled
NCT04162431
2024-06-11
DOLPHIN-VIVO
University of Exeter
Completed
50 enrolled